IL-9 treatment prior to cell infection with T. cruzi TCTs (pretreatment) significantly reduced the number of infected cells and intracellular parasites in the C2C12 myoblasts and bone marrow-derived macrophages (Figure 1). The gene discussed is IL9; the disease is infection.